CpG-adjuvanted hepatitis B vaccine (HEPLISAV-B®) update
GH Lee, SG Lim - Expert Review of Vaccines, 2021 - Taylor & Francis
Introduction: HEPLISAV-B is a hepatitis B vaccine composed of rHBsAg mixed with a
synthetic oligonucleotide containing CpG motifs that stimulate innate immunity through …
synthetic oligonucleotide containing CpG motifs that stimulate innate immunity through …
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest
rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection …
rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection …
Chronic hepatitis B in Asia—new insights from the past decade
HLY Chan, J Jia - Journal of gastroenterology and hepatology, 2011 - Wiley Online Library
Chronic hepatitis B virus (HBV) infection is a major health problem in the Asia‐Pacific
region. In the past decade, much progress has been made in the understanding and …
region. In the past decade, much progress has been made in the understanding and …
Serum Exosomal Long Noncoding RNAs ENSG00000258332.1 and LINC00635 for the Diagnosis and Prognosis of Hepatocellular Carcinoma
H Xu, Y Chen, X Dong, X Wang - Cancer Epidemiology, Biomarkers & …, 2018 - AACR
Background: Increasing studies suggest that long noncoding RNAs (lncRNAs) are involved
in carcinogenesis of human cancers and might be used as diagnostic biomarkers for …
in carcinogenesis of human cancers and might be used as diagnostic biomarkers for …
[PDF][PDF] Prevention and control of viral hepatitis infection: framework for global action
World Health Organization - 2012 - apps.who.int
病毒性肝炎感染的 预防与控制: Page 1 病毒性肝炎感染的 预防与控制: 全球行动框架 Page 2 ©
世界卫生组织,2012年.版权所有. 本出版物采用的名称和陈述的材料并不代表世界卫生组织对任何 …
世界卫生组织,2012年.版权所有. 本出版物采用的名称和陈述的材料并不代表世界卫生组织对任何 …
CRISPR/Cas12-based ultra-sensitive and specific point-of-care detection of HBV
R Ding, J Long, M Yuan, X Zheng, Y Shen… - International journal of …, 2021 - mdpi.com
Hepatitis B remains a major global public health challenge, with particularly high prevalence
in medically disadvantaged western Pacific and African regions. Although clinically …
in medically disadvantaged western Pacific and African regions. Although clinically …
Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles
Alginate coated chitosan nanoparticles were previously developed with the aim of protecting
the antigen, adsorbed on the surface of those chitosan nanoparticles, from enzymatic …
the antigen, adsorbed on the surface of those chitosan nanoparticles, from enzymatic …
Knowledge, attitudes and practices toward hepatitis B virus infection among students of medicine in Vietnam
TTL Nguyen, TTH Pham, S So, THV Hoang… - International journal of …, 2021 - mdpi.com
Background: Building capacity in hepatitis B virus prevention and management for medical
students and health professionals is one of the pillars of the national viral hepatitis control …
students and health professionals is one of the pillars of the national viral hepatitis control …
Prevention of hepatocellular carcinoma in hepatitis B virus infection
Chronic hepatitis B is the main risk factor for hepatocellular carcinoma (HCC) in Asia. The
most important preventive strategy's adoption of the universal hepatitis B vaccination …
most important preventive strategy's adoption of the universal hepatitis B vaccination …
[HTML][HTML] Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases
M Kawanaka, K Nishino, H Kawamoto… - World Journal of …, 2021 - ncbi.nlm.nih.gov
New hepatitis B virus (HBV) infections are decreasing owing to improved antiviral therapy
and increased HBV vaccination worldwide; however, the number of HBV infections remains …
and increased HBV vaccination worldwide; however, the number of HBV infections remains …